tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gary Nachman, 162 are a BUY (67.22%), 77 are a HOLD (31.95%), 2 are a SELL (0.83%).
Analyst Gary Nachman, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 48.59% that have a potential upside of 53.23% achieved within 504 days. Previously, Gary Nachman worked at CANACCORD.
Gary Nachman’s has documented 507 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 22-Jul-2026.
Analyst best performing recommendations are on LENZ (LENZ THERAPEUTICS).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) at 2/14/2018. The price target of $32 was fulfilled within 2 days with a profit of $4.1 (11.36%) receiving and performance score of 56.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 26-Aug-2025
$20
$1.28 (6.84%)
1 months 2 days ago
(29-Jun-2026)
2/3 (66.67%)
$-0.71 (-3.43%)
26
Hold Since 08-Apr-2026
$20
$-1.78 (-8.17%)
$23
1 months 28 days ago
(03-Jun-2026)
4/7 (57.14%)
$1.88 (10.38%)
61
Buy Since 22-Nov-2024
$19
$-2.78 (-12.76%)
$35
2 months 17 days ago
(14-May-2026)
1/3 (33.33%)
$1.7 (9.83%)
13
Hold Since 21-Mar-2025
$21
$-0.78 (-3.58%)
$25
2 months 20 days ago
(11-May-2026)
12/19 (63.16%)
$2.55 (13.82%)
285
Buy Since 22-Oct-2025
$30
2 months 23 days ago
(08-May-2026)
9/13 (69.23%)
$9.77 (48.29%)
299
Which stock is Gary Nachman is most bullish on?
Which stock is Gary Nachman is most reserved on?
What Year was the first public recommendation made by Gary Nachman?
